Join us on Wednesday, February 2nd from 4-5:30pm (Pacific) for a panel discussion with three clinician-scientists working on technology innovations for psychotic disorders that leverage Extended Reality (XR). The field of XR encompasses Virtual Reality (VR), Mixed Reality (MR) and Augmented Reality (AR). We hope for this panel to provide an engaging and accessible introduction to current research and evidence-based treatment approaches in this rapidly evolving field.

Savita Bhakta, MD (UC San Diego School of Medicine) will present a virtual reality-based EEG paradigm to assess neurophysiological markers of treatment response to targeted cognitive training in schizophrenia patients. She will discuss preliminary findings showing the validity, feasibility and reliability of this novel VR-EEG paradigm in schizophrenia patients and healthy controls. 

Alexandre Dumais, MD, FRCPC (U of Montreal) will discuss use of VR-assisted Cognitive Behavior Therapy (CBT) in treating schizophrenia and results of a recent randomized controlled trial showing potential benefits over generic CBT. (Dellazizzo, L., Potvin, S., Phraxayavong, K., & Dumais, A. (2021). One-year randomized trial comparing virtual reality-assisted therapy to cognitive-behavioral therapy for patients with treatment-resistant schizophrenia. NPJ schizophrenia, 7(1), 9. https://doi-org.laneproxy.stanford.edu/10.1038/s41537-021-00139-2)  

Alexandre Hudon, MD (U of Montreal), a psychiatry resident, will also discuss his clinical work treating psychotic symptoms with VR.

This event will take place over Zoom (link).